Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RVL PHARMACEUTICALS PLC

(RVLP)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 29-09-2022
2.200 USD    0.00%
30/08RVL Pharmaceuticals gaat een marketingpartnerschap aan met Revision Skincare
MT
30/08Revision Skincareģ kondigt strategisch partnerschap aan met RVL Pharmaceuticals plc
CI
22/08RVL dient registratieverklaring in namens verkopende aandeelhouders
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť RVL PHARMACEUTICALS PLC
12/09Rvl Pharmaceuticals : View Presentation
PU
30/08RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment..
AQ
30/08Revision Skincareģ Announces Strategic Partnership with RVL Pharmaceuticals plc
AQ
11/08RVL PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Condition an..
AQ
11/08Rvl Pharmaceuticals : Reports Second Quarter 2022 Financial Results; Provides Commercial U..
PU
11/08Rvl Pharmaceuticals Plc : Results of Operations and Financial Condition, Change in Directo..
AQ
11/08RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commerc..
AQ
05/08Rvl Pharmaceuticals : Material Definitive Agreement - Form 8-K
PU
04/08Rvl Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Creation of a Direct..
AQ
04/08RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing
AQ
04/08RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Co..
AQ
07/07Rvl Pharmaceuticals : Announces Preliminary Second Quarter 2022 UPNEEQģ Net Product Sales ..
PU
07/07RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQģ Net Product S..
AQ
17/06Rvl Pharmaceuticals Plc : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
16/06RVL Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting
AQ
16/05RVL Pharmaceuticals plc to Present at Upcoming Conferences
AQ
12/05RVL PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Condition an..
AQ
12/05RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commerci..
AQ
09/05UPNEEQģ Wins Best Professional-Treatment Product by Shape Magazine in the 2022 "Shape H..
PR
05/05RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Com..
AQ
11/04Rvl Pharmaceuticals Plc : Change in Directors or Principal Officers (form 8-K)
AQ
06/04Rvl Pharmaceuticals : Announces Preliminary First Quarter 2022 UPNEEQģ Net Product Sales R..
PU
06/04UPNEEQģ Wins "Best in Innovation" Award from New Beauty
PR
06/04RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQģ Net Product Sa..
AQ
04/04Rvl Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Financial Statements..
AQ
30/03Rvl Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results; Provide..
PU
30/03RVL PHARMACEUTICALS PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
30/03RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Pr..
AQ
23/03RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2021 Financial Results ..
AQ
09/03RVL Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2022
AQ
19/01UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Phar..
GL
19/01Osmotica Pharmaceuticals : Announces Corporate Name Change to RVL Pharmaceuticals plc, New..
PU
19/01Rvl Pharmaceuticals Plc : Results of Operations and Financial Condition (form 8-K)
AQ
19/01Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc..
AQ
18/01Osmotica Pharmaceuticals : Amendments to Articles of Incorporation/Bylaws/Change in Fiscal..
PU
18/01Osmotica Pharmaceuticals Plc : Amendments to Articles of Inc. or Bylaws; Change in Fiscal ..
AQ
18/01RVL Pharmaceuticals to Host UPNEEQģ Overview and Business Update Webcast on January 19,..
AQ
06/01Osmotica Pharmaceuticals plc to Host UPNEEQģ Overview and Business Update Call on Janua..
GL
2021Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
GL
2021Osmotica Pharmaceuticals : Corporate Presentation December 2021
PU
2021Osmotica Pharmaceuticals Plc : Regulation FD Disclosure (form 8-K)
AQ
2021Osmotica Pharmaceuticals : Reports Third Quarter 2021 Results and Provides Business Update..
PU
2021OSMOTICA PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Conditi..
AQ
2021Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business U..
AQ
2021Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conferen..
AQ
2021Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Updat..
AQ
2021Osmotica Pharmaceuticals Plc : Change in Directors or Principal Officers, Financial Statem..
AQ
2021Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offer..
GL
2021Osmotica Pharmaceuticals : plc Announces Closing of $35 Million Underwritten Public Offeri..
GL
2021Osmotica Pharmaceuticals : PART II INFORMATION NOT REQUIRED IN PROSPECTUS - Form 8-K
PU
2021Osmotica Pharmaceuticals Plc : Creation of a Direct Financial Obligation or an Obligation ..
AQ
2021Osmotica Pharmaceuticals : Announces Debt Financing from Athyrium Capital Management of up..
AQ
2021Osmotica Pharmaceuticals : Announces Pricing of $35 Million Underwritten Public Offering
AQ
2021Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering
GL
2021Osmotica Pharmaceuticals : plc Announces Proposed Underwritten Public Offering
GL
2021Osmotica Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Creation of a D..
AQ
2021Osmotica Pharmaceuticals Plc : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
2021Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference ..
GL
2021Osmotica Pharmaceuticals : Sales Agreement (Form 8-K)
PU
2021Osmotica Pharmaceuticals : RISK FACTORS (Form 8-K)
PU
2021Osmotica Pharmaceuticals Plc : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Osmotica Pharmaceuticals : to Present at H.C. Wainwright 23rd Annual Global Investment Con..
AQ
2021Osmotica Pharmaceuticals : UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATIO..
PU
2021Osmotica Pharmaceuticals Plc : Completion of Acquisition or Disposition of Assets, Trigger..
AQ
2021Osmotica Pharmaceuticals : Closes Sale of Legacy Business to Alora Pharmaceuticals, LLC
AQ
2021Osmotica Pharmaceuticals : Reports Second Quarter 2021 Results and Provides Business Updat..
PU
2021Osmotica Pharmaceuticals : Management's Discussion and Analysis of Financial Condition and..
AQ
2021Osmotica Pharmaceuticals : Reports Second Quarter 2021 Results and Provides Business Updat..
AQ
2021Osmotica Pharmaceuticals : to Present at H.C. Wainwright Ophthalmology Virtual Conference ..
AQ
2021Osmotica Pharmaceuticals : to Provide Second Quarter 2021 Business and Financial Update on..
AQ
2021Osmotica Subsidiary RVL Pharmaceuticals, Focused on Eye Care and Ocular Aesthetics, Str..
GL
2021Osmotica Pharmaceuticals : Announces Conclusion of Strategic Process with Agreement for th..
PU
2021Osmotica Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Regulation FD D..
AQ
2021Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement f..
GL
2021Osmotica Pharmaceuticals : Amended and restated 2018 INCENTIVE PLAN (Form 8-K)
PU
1  2  3Volgende
Volgende evenement op RVL PHARMACEUTICALS PLC